ImmunoPrecise Antibodies Ltd. financial data

Symbol
IPA on Nasdaq
Industry
Pharmaceutical Preparations
Location
3204 4464 Markham St., Victoria, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
April 30
Latest financial report
6-K - Q3 2024 - Dec 10, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.9M shares +7.56%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 5.06M CAD +38.3%
General And Administrative Expense 15.7M CAD -1.06%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill 7.92M CAD -58.2%
Assets 60M CAD -20.7%
Liabilities 27.3M CAD +15.7%